PolyPeptide Group AG (SWX: PPGN)
Switzerland
· Delayed Price · Currency is CHF 28.25
0.00 (0.00%)
Oct 8, 2024, 9:21 AM CET
PolyPeptide Group AG Revenue
PolyPeptide Group AG had revenue of 135.04M EUR in the half year ending June 30, 2024, with 1.04% growth. This brings the company's revenue in the last twelve months to 323.58M, up 15.91% year-over-year. In the year 2023, PolyPeptide Group AG had annual revenue of 320.37M with 14.02% growth.
Revenue (ttm)
323.58M EUR
Revenue Growth
+15.91%
P/S Ratio
2.97
Revenue / Employee
254.19K EUR
Employees
1,273
Market Cap
931.79M CHF
Revenue Chart
* This company reports financials in EUR.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Roche Holding AG | 60.58B |
| Roche Holding AG | 60.58B |
| Novartis AG | 43.91B |
| Lonza Group AG | 6.70B |
| Straumann Holding AG | 2.54B |
| Galderma Group AG | 3.88B |
| Sonova Holding AG | 3.63B |
| Ypsomed Holding AG | 548.46M |